immunohistochemistry staining method: Clinical Trials

54 trials of immunohistochemistry staining method, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 completed, 10 terminated, 2 withdrawn, 1 unknown. 54 Phase 1, 18 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 154Completed 41, Terminated 10, Withdrawn 2, Unknown 1
Phase 218Completed 12, Terminated 5, Unknown 1

Follow immunohistochemistry staining method: new trials by email Literature Review of immunohistochemistry staining method trials Research Report on immunohistochemistry staining method

Trials (filtered) newest first · largest first

All 54 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
HLA-A2 restricted synthetic tumor antigen, Imiquimod, enzyme-linked immunosorbent assay - Ependymoma
Phase 1TerminatedJames Felker232012-08-012026-02-05
FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Oxaliplatin, Irinotecan, Leucovorin - Pancreatic Neoplasms
Phase 1CompletedWashington University School of Medicine442012-04-012016-09-19
Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma
cyclophosphamide, aldesleukin, autologous tumor cell vaccine - Recurrent Melanoma, Stage IV Melanoma
Phase 1CompletedFred Hutchinson Cancer Center122012-03-012014-04-21
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer
fluorouracil, leucovorin calcium, oxaliplatin - Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction
Phase 1 / Phase 2CompletedCity of Hope Medical Center62012-02-012017-05-31
Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy
everolimus, erlotinib hydrochloride, biopsy - Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer
Phase 1WithdrawnFox Chase Cancer Center2011-04-012023-04-04
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
everolimus, lenalidomide, laboratory biomarker analysis - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Phase 1 / Phase 2CompletedMayo Clinic582011-01-102020-10-22
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
bafetinib, microdialysis, pharmacological study - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma
Phase 1CompletedCity of Hope Medical Center72010-12-012018-04-17
Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
entinostat, imatinib mesylate, laboratory biomarker analysis - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)22010-10-012017-08-08
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
letrozole, panobinostat, RNA analysis - Breast Cancer
Phase 1 / Phase 2CompletedAlliance for Clinical Trials in Oncology282010-09-012017-06-27
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
flucytosine, polymerase chain reaction, immunohistochemistry staining method - Adult Anaplastic Astrocytoma, Recurrent Grade III Glioma
Phase 1CompletedCity of Hope Medical Center152010-08-012017-11-09
Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
azacitidine, lenalidomide, dexamethasone - Refractory Multiple Myeloma
Phase 1 / Phase 2CompletedCase Comprehensive Cancer Center452010-06-012020-11-16
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
panobinostat, everolimus, laboratory biomarker analysis - Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer
Phase 1 / Phase 2TerminatedRoswell Park Cancer Institute262010-03-012022-08-15
AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors
multikinase inhibitor AT9283, enzyme-linked immunosorbent assay, immunohistochemistry staining method - Unspecified Childhood Solid Tumor, Protocol Specific
Phase 1CompletedCancer Research UK332009-09-012019-11-29
Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
vorinostat, protein expression analysis, immunohistochemistry staining method - Breast Cancer
Phase 1CompletedUniversity of California, San Francisco172009-07-012017-08-07
Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma
therapeutic autologous lymphocytes, aldesleukin, denileukin diftitox - Recurrent Melanoma, Stage III Melanoma
Phase 1 / Phase 2TerminatedFred Hutchinson Cancer Center32009-07-012022-11-15
Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer
immunohistochemistry staining method, laboratory biomarker analysis, pharmacological study - Prostate Cancer
Phase 1TerminatedCancer Research UK82009-06-012012-02-28
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
systemic chemotherapy, RNA analysis, gene expression analysis - Colorectal Cancer
Phase 1WithdrawnBarbara Ann Karmanos Cancer Institute2009-06-012013-04-16
Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
decitabine, NY-ESO-1 peptide vaccine, pegylated liposomal doxorubicin hydrochloride - Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer
Phase 1CompletedRoswell Park Cancer Institute182009-04-012022-08-01
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
bevacizumab, FOLFOX regimen, fluorouracil - Colorectal Cancer
Phase 1CompletedCity of Hope Medical Center112009-03-112025-06-22
Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma
epirubicin hydrochloride, ifosfamide, sorafenib tosylate - Sarcoma
Phase 1CompletedOHSU Knight Cancer Institute182009-02-012018-09-07

Showing 20 of 54. Sign in to see all of them.

Conditions studied

Breast Neoplasms (7)  ·  Melanoma (7)  ·  Prostatic Neoplasms (4)  ·  Astrocytoma (3)  ·  Brain Neoplasms (3)  ·  Breast Neoplasms, Male (3)  ·  Burkitt Lymphoma (3)  ·  Carcinoma, Ovarian Epithelial (3)  ·  Carcinoma, Renal Cell (3)  ·  Glioblastoma (3)  ·  Gliosarcoma (3)  ·  Head and Neck Neoplasms (3)  ·  Lung Neoplasms (3)  ·  Lymphoma, B-Cell, Marginal Zone (3)  ·  Lymphoma, Follicular (3)

Sponsors

City of Hope Medical Center (9)  ·  Fred Hutchinson Cancer Center (4)  ·  Memorial Sloan Kettering Cancer Center (3)  ·  NCIC Clinical Trials Group (3)  ·  National Cancer Institute (NCI) (3)  ·  University of California, Davis (3)  ·  Abramson Cancer Center at Penn Medicine (2)  ·  Cancer Research UK (2)  ·  Case Comprehensive Cancer Center (2)  ·  Mayo Clinic (2)  ·  Roswell Park Cancer Institute (2)  ·  University of California, San Francisco (2)  ·  AIDS Malignancy Consortium (1)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Barbara Ann Karmanos Cancer Institute (1)

Countries

United States (42)  ·  Canada (4)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Ireland (1)  ·  Switzerland (1)

Top investigators

Angela Davies, MD (2)  ·  Cassian Yee (2)  ·  Jana Portnow (2)  ·  Sylvia Lee (2)  ·  Ahmad Awada, MD, PhD (1)  ·  Amit Maity (1)  ·  Andrea Wang-Gillam, M.D., PhD (1)  ·  Anthony Fyles, MD (1)  ·  Arthur Blackstock (1)  ·  Aude Chapuis (1)  ·  Bhaumik B. Patel, MD (1)  ·  Brian H. Kushner, MD (1)  ·  Christopher W. Ryan, MD (1)  ·  Craig Reeder, M.D. (1)  ·  Darren Hargrave, MD (1)

Results publications

PMID 18090584, PMID 21285985, PMID 22044694, PMID 22160854, PMID 22989664, PMID 23380277, PMID 26774555, PMID 27055731, PMID 27269940, PMID 28679643, PMID 31436839, PMID 31654285, PMID 34944886

NIH funding

P30CA033572 (4), K12CA076930 (3), P30CA093373 (2), N01CN35158 (1), P30CA015083 (1), P30CA016086 (1), P30CA043703 (1), P30CA069533 (1), P30CA072720 (1), P50CA107399 (1), R01CA174858 (1), R21CA128283 (1), R21CA137647 (1), U01CA062490 (1), U01CA070095 (1)